A case of sintilimab-induced SJS/TEN:Dermatologic adverse reactions associated with programmed cell death protein-1 inhibitors.
Dermatol Ther
; 35(9): e15663, 2022 09.
Article
in En
| MEDLINE
| ID: mdl-35739068
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Stevens-Johnson Syndrome
/
Immune Checkpoint Inhibitors
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Dermatol Ther
Journal subject:
DERMATOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
United States